PT Lippo Karawaci Tbk
LPKR.JK · Indonesia Stock Exchange · IDR
42,00IDR
−1,00 (−2,33 %)Stand 11. Nov., 9:14
Kennzahlen
- Eröffnung
- 43,00
- Vortag
- 43,00
- Tagesspanne
- 41,00 – 43,00
- 52 Wochen
- 37,00 – 143,00
- Volumen
- 32,34 Mio.
- Ø Volumen
- 157,5 Mio.
- Börsenwert
- 2,98 Bio. IDR
- KGV
- 2,2
- Gewinn je Aktie (TTM)
- 18,91
- Dividendenrendite
- 0,0 %
- Beta
- 0,6
- Nächste Zahlen
- 1. Apr. 2027
Finanzen
| IDR | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Umsatz | 8,84 Bio. | 11,35 Bio. | 16,85 Bio. | 14,67 Bio. | 16,14 Bio. |
| Herstellungskosten | 6,31 Bio. | 6,55 Bio. | 9,75 Bio. | 8,52 Bio. | 10,59 Bio. |
| Bruttogewinn | 2,53 Bio. | 4,79 Bio. | 7,09 Bio. | 6,15 Bio. | 5,55 Bio. |
| Forschung und Entwicklung | 0 | 0 | 0 | 0 | 0 |
| Vertrieb und Verwaltung | 797,17 Mrd. | 1,1 Bio. | 1,52 Bio. | 1,42 Bio. | 1,43 Bio. |
| Operatives Ergebnis | 612,49 Mrd. | 20,28 Bio. | 3,69 Bio. | −39,11 Mrd. | 625,25 Mrd. |
| EBITDA | 1,12 Bio. | 21,44 Bio. | 4,45 Bio. | 1,49 Bio. | 3,85 Bio. |
| Nettogewinn | 469,54 Mrd. | 18,75 Bio. | 50,14 Mrd. | −2,33 Bio. | −1,62 Bio. |
| Gewinn je Aktie (verwässert) | 6,62 | 264,49 | 1,10 | -50,94 | -22,93 |
Bewertung
Letzte 12 Monate
- KGV
- 2,2
- Kurs-Umsatz-Verhältnis
- 0,4
- Kurs-Buchwert-Verhältnis
- 0,1
- PEG
- 0,0
- Bruttomarge
- 35,4 %
- Operative Marge
- 9,3 %
- Nettomarge
- 17,3 %
- Verschuldungsgrad
- 0,3
- EV/EBITDA
- 7,1
- Eigenkapitalrendite
- 4,4 %
- Kapitalrendite (ROIC)
- 1,5 %
- Free-Cashflow-Rendite
- −30,2 %
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |
|---|---|---|---|---|---|
| Bruttomarge | 28,6 % | 42,2 % | 42,1 % | 41,9 % | 34,4 % |
| Operative Marge | 6,9 % | 178,7 % | 21,9 % | −0,3 % | 3,9 % |
| Nettomarge | 5,3 % | 165,2 % | 0,3 % | −15,9 % | −10,1 % |
| KGV | 12,7 | 0,4 | 88,2 | -1,6 | -6,1 |
| Kurs-Umsatz-Verhältnis | 0,7 | 0,4 | 0,3 | 0,2 | 0,6 |
| Kurs-Buchwert-Verhältnis | 0,2 | 0,2 | 0,3 | 0,2 | 0,5 |
| Verschuldungsgrad | 0,3 | 0,3 | 1,3 | 1,4 | 1,1 |
| Liquidität 3. Grades | 4,1 | 3,1 | 3,0 | 3,1 | 3,3 |
| Dividendenrendite | 0,0 % | 0,0 % | 0,0 % | 0,0 % | 0,0 % |
| Unternehmenswert | 13,64 Bio. | 9,54 Bio. | 22,05 Bio. | 22,17 Bio. | 24,96 Bio. |
| EV/EBITDA | 12,1 | 0,4 | 5,0 | 14,9 | 6,5 |
| Eigenkapitalrendite | 1,6 % | 62,8 % | 0,3 % | −15,2 % | −8,7 % |
| Kapitalrendite (ROIC) | 1,2 % | 43,7 % | 4,4 % | −0,1 % | 1,4 % |
| Free-Cashflow-Rendite | −30,6 % | 25,7 % | 21,5 % | −57,0 % | 11,8 % |
Wachstum
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |
|---|---|---|---|---|---|
| Umsatz | −22,1 % | −32,6 % | +14,8 % | −9,1 % | +36,6 % |
| Bruttogewinn | −47,2 % | −32,4 % | +15,4 % | +10,8 % | +34,3 % |
| Operatives Ergebnis | −97,0 % | +449,0 % | +9.543,8 % | −106,3 % | +840,5 % |
| Nettogewinn | −97,5 % | +37.287,4 % | +102,2 % | −43,4 % | +83,2 % |
| Gewinn je Aktie | −97,5 % | +23.944,5 % | +102,2 % | −122,2 % | +83,2 % |
| Freier Cashflow | −252,2 % | +25,6 % | +146,4 % | −275,2 % | +140,7 % |
| Dividende je Aktie | 0,0 % | 0,0 % | 0,0 % | 0,0 % | 0,0 % |
Analysten
Einstufungen
Gerade nicht verfügbar.
Kursziel
Gerade nicht verfügbar.
Schätzungen
| FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|
| Umsatz (Ø) | 7,75 Bio. | 8,23 Bio. | 8,35 Bio. |
| Umsatz (Tief – Hoch) | 7,6 Bio. – 7,9 Bio. | 7,55 Bio. – 8,91 Bio. | 7,61 Bio. – 9,09 Bio. |
| Gewinn je Aktie (Ø) | 9,20 | 9,20 | 11,50 |
| Gewinn je Aktie (Tief – Hoch) | 8,38 – 10,02 | 6,22 – 12,18 | 7,67 – 15,33 |
| Analysten | 2 | 2 | 2 |
Quartalszahlen
Nächste Zahlen: 1. Apr. 2027| Okt. 2026 | Juli 2026 | Apr. 2026 | März 2026 | Okt. 2025 | Aug. 2025 | Apr. 2025 | Nov. 2024 | |
|---|---|---|---|---|---|---|---|---|
| Gewinn je Aktie · Erwartet | – | – | – | – | – | – | – | 1,58 |
| Gewinn je Aktie · Tatsächlich | 12,04 | 3,93 | 1,51 | 1,43 | 3,25 | -0,45 | 3,71 | -16,52 |
| Abweichung | – | – | – | – | – | – | – | −1.145,41 % |
| Umsatz · Tatsächlich | 1,76 Bio. | 1,81 Bio. | 1,76 Bio. | 2,53 Bio. | 2,34 Bio. | 2,05 Bio. | 2,02 Bio. | 1,22 Bio. |
Dividenden und Splits
| Ex-Tag | Zahltag | Betrag |
|---|---|---|
| 22. Juni 2018 | 6. Juli 2018 | 2,14 |
| 3. Apr. 2017 | 21. Apr. 2017 | 1,54 |
| 4. Apr. 2016 | – | 2,78 |
| 22. Juni 2015 | – | 13,24 |
| 3. Dez. 2014 | – | 11,15 |
| 2. Dez. 2013 | – | 9,40 |
| 28. Aug. 2012 | – | 6,18 |
| 6. Okt. 2011 | – | 3,44 |
| 12. Nov. 2010 | – | 2,17 |
| 5. Dez. 2007 | – | 2,79 |
| 4. Dez. 2006 | – | 6,03 |
Aktiensplits
- 24. Juni 201963:50
- 8. Dez. 20101051:1000
- 26. Dez. 20075:2
- 28. Juli 20062:1
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
–
Vergleichbare Unternehmen
APLN.JKPT Agung Podomoro Land Tbk81,00−1,22 %
ASRI.JKPT Alam Sutera Realty Tbk94,00+1,08 %
BKSL.JKPT Sentul City Tbk38,000,00 %
CTRA.JKPT Ciputra Development Tbk498,00−0,40 %
DILD.JKPT Intiland Development Tbk101,000,00 %
DUTI.JKPT Duta Pertiwi Tbk4.420,00−6,95 %
ELTY.JKPT Bakrieland Development Tbk17,00−5,56 %
JRPT.JKPT Jaya Real Property, Tbk.1.175,00−0,42 %
Über das Unternehmen
PT Lippo Karawaci Tbk, an Indonesian conglomerate operating through its subsidiaries, specializes in comprehensive property development. Its operations are structured across three primary divisions: Real Estate Development, Real Estate Management & Services, and Fund Management/Investments. The Real Estate Development division is responsible for extensive real estate activities, encompassing urban planning, infrastructure creation, and the execution of expansive, integrated projects. These developments include residential condominiums, commercial and entertainment centers, office complexes, and facilities dedicated to healthcare and education. This segment also incorporates a food business and other strategic investments. The Real Estate Management & Services division focuses on the development and operation of shopping centers, hotels, recreational venues, and restaurants. Furthermore, it delivers essential services such as health and town management, water and sewage treatment, alongside transportation and maintenance solutions. The Fund Management/Investments segment primarily offers specialized management services. Beyond these core property offerings, the company engages in a vast array of complementary activities. These include financial, professional, scientific, and technical services; construction; various aspects of transportation and trading; comprehensive water, wastewater, waste management, and recycling solutions; parking and remediation services; and staffing provisions. A significant part of its portfolio also involves operating hospitals, clinics, health centers, polyclinics, and providing other related healthcare services. Its extended business interests span investments, printing, agriculture, gardening, workshop operations, pharmaceutical wholesale, mining, computer programming, diverse management consulting, hotel management, township development, asset management, home care, and air installation. As of December 31, 2021, Lippo Karawaci's extensive portfolio included 40 hospitals, 59 malls (comprising 49 leased and 10 strata-titled properties), and 10 hotels. Established in 1990 under its former name, PT Tunggal Reksakencana, the company maintains its headquarters in Tangerang, Indonesia.
Führung
- Danang Kemayan JatiHead of Corporate Communications
- Agus ArismunandarHead of Investor relations, Corporate Secretary & Director
- Alwi Rubidium SjaafChief Development Officer
- Dominique Dion LeswaraChief Human Resources & Administration Officer and Director
- Ernest AltoHead of Internal Audit
- Fendi SantosoCFO & Director
- CEO
- Marlo Budiman
- Mitarbeitende
- 1.765
- Hauptsitz
- Tangerang, BT, ID
- Sektor
- Real Estate
- Branche
- Real Estate - Development
- Börsengang
- 29. Sept. 2005
- Website
- lippokarawaci.co.id
Nachrichten
Gerade keine Nachrichten zu diesem Unternehmen.
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.